McKinsey

Response of WHO to KEI letter regarding McKinsey, vaccine policy and competing interests

On 20 February 2011, Dr. Keiji Fukuda, Assistant Director-General - Health Security and Environment, World Health Organization, responded to KEI's letter (16 February 2011) regarding McKinsey, vaccine policy and competing interests. Here is the response in full (email contacts have been redacted).

From: "Fukuda, Keiji"
Date: February 20, 2011 4:14:05 PM GMT+01:00
To: "Thiru Balasubramaniam"

KEI letter to WHO regarding McKinsey, vaccine policy and competing interests

On 15 February 2011, the Co-Chairs of the WHO Open-Ended Working Group of Member States on Pandemic Influenza Preparedness: sharing of influenza viruses and access to vaccines and other benefits (OEWG) held a consultation with civil society. The Co-chairs of the OEWG are Ambassador J. Gomez-Camacho, Mexico and Ambassador B. Angell-Hansen, Norway.

Syndicate content